15:33 IST
BSE
Annual Report
Indo US Bio-Tech Annual Report
Indo Us Bio-Tech Ltd submitted its Annual Report for FY 2025-2026. The 22nd Annual General Meeting is scheduled for September 30, 2026.
Indo US Bio-Tech Ltd
- Share price
- ₹77.60
- Market cap
- ₹155.6 Cr
- Revenue (annual)
- ₹110.4 Cr
- Net profit (annual)
- ₹13.12 Cr
- P/E (TTM)
- 13.6×Sector 29.0×
- Promoter holding
- 68.29%+0.00% QoQ
- FII holding
- 0.01%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
Announcement type
Time
5 announcements
15:07 IST
NSE
Annual General Meeting
Indo US Bio-Tech Annual General Meeting
Indo Us Bio-Tech Limited has issued a notice for its 22nd Annual General Meeting, scheduled for September 30, 2026, to be conducted via video conferencing.
14:57 IST
BSE
Board Meeting Outcome
Indo US Bio-Tech Board Meeting Outcome
Indo Us Bio-Tech Ltd announced outcomes of its board meeting, including the date for its 22nd AGM and appointment of statutory auditors.
15:24 IST
BSE
Financial Results
Indo US Bio-Tech Q1 FY27 Results: Net Profit ₹3 Cr, Down 36.2% YoY
Indo US Bio-Tech Ltd reported revenue from operations of ₹33 Cr (+7.1% YoY) and net profit of ₹3 Cr (-36.2% YoY) for Q1 FY27.
- Key figure
- Net profit ₹3 Cr · -36.2% YoY
18:20 IST
NSE
Financial Results
Indo US Bio-Tech Q4 FY26 Results: Net Profit ₹2 Cr, Down 45.9% YoY
Indo US Bio-Tech Ltd reported revenue from operations of ₹26 Cr (-22.2% YoY) and net profit of ₹2 Cr (-45.9% YoY) for Q4 FY26.
- Key figure
- Net profit ₹2 Cr · -45.9% YoY